Merkel Cell Polyomavirus and Cutaneous Merkel Cell Carcinoma

References

• Lebbe C, Becker JC, Grob JJ et al. Diagnosis and treatment of Merkel cell carcinoma. European consensus-based interdisciplinary guideline. Eur. J. Cancer 51(16), 2396–2403 (2015).
   PubMed Web of Science ®Google Scholar
• Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319(5866), 1096–1100 (2008).
   PubMed Web of Science ®Google Scholar
• Martel-Jantin C, Filippone C, Cassar O et al. Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology 426(2), 134–142 (2012).
   PubMed Web of Science ®Google Scholar
• Spurgeon ME, Lambert PF. Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology 435, 118–130 (2013).
   PubMed Web of Science ®Google Scholar
• Schrama D, Becker JC. Merkel cell carcinoma – pathogenesis, clinical aspects and treatment. J. Eur. Acad. Dermatol. Venereol. 25, 1121–1129 (2011).
   PubMed Web of Science ®Google Scholar
• Sihto H, Kukko H, Koljonen V, Sankila R, Boehling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J. Natl Cancer Inst. 101, 938–945 (2009).
   PubMedGoogle Scholar
• Rodig SJ, Cheng J, Wardzala J et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J. Clin. Invest. 122(12), 4645–4653 (2012).
   PubMed Web of Science ®Google Scholar
• Pantulu ND, Pallasch CP, Kurz AK et al. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 116(24), 5280–5284 (2010).
   PubMed Web of Science ®Google Scholar
• Harms PW, Patel RM, Verhaegen ME et al. Distinct gene expression profiles of viral- and nonviral-associated Merkel cell carcinoma revealed by transcriptome analysis. J. Invest. Derm. 133, 936–945 (2013).
   PubMed Web of Science ®Google Scholar
• Erstad DJ, Cusack JC Jr. Mutational analysis of Merkel cell carcinoma. Cancers 6(4), 2116–2136 (2014).
   PubMed Web of Science ®Google Scholar
• Paulson KG, Iyer JG, Tegeder AR et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J. Clin. Oncol. 20(12), 1539–1546 (2011).
   Google Scholar
• Miner AG, Patel RM, Wilson DA et al. Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod. Pathol. 28, 498–504 (2015).
   PubMed Web of Science ®Google Scholar
• Martin B, Poblet E, Rios JJ et al. Merkel cell carcinoma with divergent differentiation: histopathological and immunohistochemical study of 15 cases with PCR analysis for Merkel cell polyomavirus. Histopathology 62(5), 711–722 (2013).
   PubMed Web of Science ®Google Scholar
• Higaki-Mori H, Kuwamoto S, Iwasaki T et al. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum. Pathol. 43(12), 2282–2291 (2012).
   PubMed Web of Science ®Google Scholar
• Tothill R, Estall V, Rischin D. Merkel cell carcinoma: emerging biology, current approaches and future directions. Am. Soc. Clin. Oncol. Educ. Book 2015, e519–e526 (2015).
   PubMedGoogle Scholar
• Peitsch WK. Associations between Merkel cell carcinoma and Merkel cell polyomavirus. Br. J. Dermatol. 173(1), 7–8 (2015).
   PubMed Web of Science ®Google Scholar
• Loyo M, Schussel J, Colantuoni E et al. Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. Br. J. Cancer 106(7), 1314–1319 (2012).
   PubMed Web of Science ®Google Scholar
• Amber K, McLeod MP, Nouri K. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol. Surg. 39, 232–238 (2013).
   PubMed Web of Science ®Google Scholar
• Gaiser MR, Daily K, Hoffmann J, Brune M, Enk A, Brownell I. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers. Oncotarget 6(28), 26472–26482 (2015).
   PubMedGoogle Scholar
• Blom A, Bhatia S, Pietromonaco S et al. Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma. J. Am. Acad. Dermatol. 70(3), 449–455 (2014).
   PubMed Web of Science ®Google Scholar
• Lipson EJ, Vincent JG, Loyo M et al. PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. Cancer Immunol. Res. 1, 54–63 (2013).
   PubMed Web of Science ®Google Scholar
• Afanasiev OK, Yelistratova L, Miller N et al. Merkel polyomavirus-specific T cells fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clin. Cancer Res. 19, 5351–5360 (2013).
   PubMed Web of Science ®Google Scholar
• Nghiem PT, Bhatia S, Lipson EJ et al. PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma. N. Engl. J. Med. 374(26), 2542–2552 (2016).
   PubMed Web of Science ®Google Scholar
• Sanlorenzo M, Vujic I, Daud A et al. Pembrolizumab cutaneous adverse events and their association with disease progression. JAMA Dermatol. 151(11), 1206–1212 (2015).
   PubMed Web of Science ®Google Scholar
• Rabinowits G. Systemic therapy for Merkel cell carcinoma: what’s on the horizon? Cancers 6, 1180–1194 (2014).
   PubMed Web of Science ®Google Scholar
• Vandeven N, Nghiem P. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas. Immunotherapy 8(8), 907–921 (2016).
   PubMed Web of Science ®Google Scholar
• Cassler NM, Merrill D, Bichakjian CK, Brownell I. Merkel cell carcinoma therapeutic update. Curr. Treat. Options Oncol. 17(7), 36 (2016).
   PubMed Web of Science ®Google Scholar